INOFEA developed a unique and patented platform technology called enzzen® to fit enzymes to process conditions.
The use of enzymes by companies is strongly limited by the fact that enzyme structure is sensitive and fragile, like most proteins, and usually not fitted to process conditions. Many expensive genetically engineered or biological enzymes show remarkable properties but need to be made more robust for deployment in various industries.
Our technology platform is unlocking the full potential value of enzymes, providing a seamless level of enhanced properties, unlike any other existing technologies.
enzzen® is capable of immobilizing any enzyme or cocktail of enzymes onto safe silica particles and protect them by growing a nano-structured shield on the outer surface of the particle. This formulation of enzymes thus prevents the process of enzyme denaturation and provides them with remarkable resistance to process conditions, such as acidity, temperature, the presence of chaotropic agents, proteases, etc.
The result is an increased efficiency of enzzen®-formulated enzymes compared to commercially available enzymes, being more robust for deployment in the healthcare industry.